DRAP
The article provides a general overview of the regulatory requirements for recall procedures for healthcare products intended to be marketed and used in Pakistan.
DRAP
The new article describes in detail the recall procedure to be followed when removing defective products from the market to ensure the safety of patients.
DRAP
The new article provides an overview of the critical responsibilities of the parties involved in recalls associated with therapeutic products, as well as additional communication details to ensure the vitally important safety information is duly delivered to the affected parties.
DRAP
The new article highlights certain specific aspects related to the recalls the parties responsible for medical devices should initiate once it is identified that such products may pose risks to public health.
DRAP
The new article highlights the aspects of clinical research concerning the products intended to be marketed and used in Pakistan.
#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET
Register Now
